PanCAD.ai Co., Ltd. is a spin-off from National Taiwan University and National Taiwan University Hospital to develop the innovative AI-assisted Detection Tool for Pancreatic Cancer—— PANCREASaver.
Main Services
PANCREASaver, an AI-based detection tool, can differentiate pancreatic cancer from normal pancreas on CT images with an accuracy exceeding 90% and facilitates the detection of PCs.
PANCREASaver has been featured in top international journals such as 'The Lancet Digital Health' and 'Radiology,' and has received recognitions, including the 'National Innovation Award,' 'National Innovation Advancement Award,' 'Symbol of National Quality (SNQ) ,' and 'Taipei Biotech Award.' The product holds four Taiwan invention patents and four U.S. invention patents. In July 2023, it received medical device approval from the Taiwan Ministry of Health and Welfare and was recognized by the U.S. FDA as a breakthrough medical device.